Comparison of percutaneous transluminal angioplasty with stenting for treatment of central venous stenosis or occlusion in hemodialysis patients: a systematic review …
TY Wu, CK Wu, YY Chen, CH Lin - CardioVascular and Interventional …, 2020 - Springer
TY Wu, CK Wu, YY Chen, CH Lin
CardioVascular and Interventional Radiology, 2020•SpringerObjectives A common cause of hemodialysis vascular access dysfunction, a primary cause
of morbidity and mortality in patients undergoing hemodialysis, is central venous stenosis or
occlusion. The present study compared percutaneous transluminal angioplasty (PTA) with
percutaneous transluminal angioplasty and stent placement (PTS) for treatment of central
venous stenosis or central vein occlusion in hemodialysis patients. Methods A systematic
literature review was conducted using database searches of PubMed, Cochrane, and …
of morbidity and mortality in patients undergoing hemodialysis, is central venous stenosis or
occlusion. The present study compared percutaneous transluminal angioplasty (PTA) with
percutaneous transluminal angioplasty and stent placement (PTS) for treatment of central
venous stenosis or central vein occlusion in hemodialysis patients. Methods A systematic
literature review was conducted using database searches of PubMed, Cochrane, and …
Objectives
A common cause of hemodialysis vascular access dysfunction, a primary cause of morbidity and mortality in patients undergoing hemodialysis, is central venous stenosis or occlusion. The present study compared percutaneous transluminal angioplasty (PTA) with percutaneous transluminal angioplasty and stent placement (PTS) for treatment of central venous stenosis or central vein occlusion in hemodialysis patients.
Methods
A systematic literature review was conducted using database searches of PubMed, Cochrane, and Embase. Articles were selected using the Population/Intervention/Comparator/Outcomes (PICO) process. Outcomes included the rate of procedural success, primary patency, assisted primary patency, re-intervention subjects, re-intervention rate, and adverse events.
Results
A total of eight studies were included in the meta-analysis with subjects in the PTA group (n = 281) or PTS group (n = 192). Primary patency rate between PTA and PTS groups at 3-, 6-, 12-, or 24-month follow-up was not different (all p > 0.05). Patients treated with PTA had greater assisted primary patency rates than the PTS group (OR = 1.03, 1.73, 1.03, and 2.00 at 3, 6, 12, and 24 months, respectively). However, the statistical assessment only showed significantly at 24-month follow-up (p = 0.01).
Conclusions
The present meta-analysis revealed that, compared to PTS, PTA may provide increased assisted primary patency for endovascular treatment of central vein stenosis or occlusion in patients undergoing hemodialysis.
Level of Evidence
Level 3a.
Springer
以上显示的是最相近的搜索结果。 查看全部搜索结果